LEADER 02497nam 2200589Ia 450 001 9910780331003321 005 20231010204315.0 010 $a0-309-16653-5 010 $a1-280-17666-0 010 $a9786610176663 010 $a0-309-52829-1 035 $a(CKB)111090425020458 035 $a(EBL)3376301 035 $a(SSID)ssj0000210321 035 $a(PQKBManifestationID)11198356 035 $a(PQKBTitleCode)TC0000210321 035 $a(PQKBWorkID)10283674 035 $a(PQKB)10658734 035 $a(MiAaPQ)EBC3376301 035 $a(Au-PeEL)EBL3376301 035 $a(CaPaEBR)ebr10055396 035 $a(CaONFJC)MIL17666 035 $a(OCoLC)923262742 035 $a(EXLCZ)99111090425020458 100 $a20031215h20042004 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNew frontiers in contraceptive research $ea blueprint for action /$fSharyl J. Nass and Jerome F. Strauss III, editors ; Committee on New Frontiers in Contraceptive Research, Board on Health Sciences Policy 210 1$aWashington, D.C. :$cNational Academies Press,$d2004. 210 4$aŠ2004 215 $a1 online resource (xiv, 232 pages) $cillustrations 311 0 $a0-309-09107-1 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Executive Summary""; ""1 Introduction""; ""2 Target Discovery and Validation""; ""3 Product Identification and Development""; ""4 Improving Contraceptive Use and Acceptability""; ""5 Capitalizing on Recent Scientific Advances""; ""APPENDIXES""; ""APPENDIX A--Examples of Progress and Impediments in Contraceptive Research and Development""; ""APPENDIX B--Agendas and Participants in Committee Workshops""; ""APPENDIX C--Committee Biographies""; ""Glossary""; ""Acronyms"" 606 $aContraception$xResearch 606 $aBirth control$xResearch 615 0$aContraception$xResearch. 615 0$aBirth control$xResearch. 676 $a613.9/4/072 701 $aNass$b Sharyl J$0857626 701 $aStrauss$b Jerome F$g(Jerome Frank),$f1947-$01568511 712 02$aInstitute of Medicine (U.S.).$bCommittee on New Frontiers in Contraceptive Research. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910780331003321 996 $aNew frontiers in contraceptive research$93840682 997 $aUNINA